Deep brain stimulation for severe obsessive-compulsive disorder
Official title: Reclaim™ Deep Brain Stimulation (DBS) Therapy for Obsessive-Compulsive Disorder (OCD)
Run by Northwell Health · NCT02773082 · Data updated 2026-11-12
This study is testing if deep brain stimulation can help people with severe obsessive-compulsive disorder who haven't found relief from other treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Northwell Health Academic / other |
| Locations | 1 site (Queens, New York) |
| Status | Recruiting |
| Started | July 6, 2024 |
| Main results expected | January 1, 2030 |
| Study ends | January 1, 2030 |
| Registry record updated | October 29, 2025 |
| Trial ID | NCT02773082 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a diagnosis of severe OCD lasting at least 5 years who have failed multiple treatment options.
✕Probably not a fit
Patients with primary hoarding disorder or those with serious comorbid psychiatric conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study explores the use of deep brain stimulation (DBS) as a treatment for patients with chronic, severe obsessive-compulsive disorder (OCD) who have not responded to traditional therapies such as medication and cognitive behavior therapy. The DBS procedure involves implanting a device that delivers electrical impulses to specific brain regions associated with mood and anxiety. Patients eligible for this intervention must have a long history of treatment-resistant OCD and meet specific medical criteria. The study aims to provide an alternative to irreversible neurosurgical procedures for these patients.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the quality of life for patients suffering from severe, treatment-resistant OCD.
How similar studies have gone: While DBS has shown promise in treating other neurological conditions, its application for OCD is still relatively novel and has not been extensively tested in large-scale studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have a diagnosis of OCD with a documented duration of at least 5 years * Have OCD rated as severe or extreme illness * Have failed to improve following treatment with at least 3 selective serotonin reuptake inhibitors (SSRIs) and clomipramine * Do not have hoarding as their primary subclassification * Have completed or tried to complete Exposure and Response Prevention Therapy (ERP) * Have no serious psychiatric disorder in addition to OCD (e.g. comorbid personality disorder) or current substance abuse issues * Meet established criteria for implantation of a deep brain stimulation system * Are 18 years old or older * Have not had a previous surgery to destroy the region of the brain that will be the target of stimulation * Are not pregnant * Have no other neurological disorders, including dementia * Do not have a bleeding disorder or are not taking blood thinners * Are capable of giving informed consent Exclusion Criteria: * Patients who are unable to properly operate the neurostimulator * Patients who will be exposed to diathermy
Where it's running
-
Zucker Hillside Hospital
Queens, New York, United States Recruiting
Study contacts
- Principal investigator: Albert J Fenoy, MD — Northwell Health
- Study coordinator: Samantha Gonzalez
- Email: sgonzalez30@northwell.edu
- Phone: 7184704152
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Focused ultrasound for mood and anxiety disorders
This study tests whether repeated low-intensity focused ultrasound using the ATTN201 device can help people with subsyndromal to moderate depression, anxiety, or OCD.
-
Predicting Treatment Response in Psychiatric Disorders Using Biological Markers
This study tests whether biological markers can predict which patients with psychiatric conditions will respond to treatment.
-
Safety and feasibility of a next-generation dome helmet for neuromodulation in OCD
This study tests whether a new focused ultrasound helmet can safely help people with treatment-refractory OCD see if their symptoms improve.
-
Bergen Four-Day Treatment for OCD, in Finland
This trial tests whether the Bergen Four-Day Treatment for OCD can be implemented in Finnish psychiatric care to help people with OCD see if the intensive program works in a real-world setting.
-
Test different deep TMS coils and targets to treat OCD
This study tests whether different deep TMS coils and brain targets help reduce OCD symptoms in adults with OCD, using a double-blind setup with sham and active stimulation.
-
Role of theta brain waves in how kids control thoughts and actions
This study tests whether theta-frequency brain activity can reveal how children with ADHD or OCD, and healthy kids, manage thinking and behavior during tasks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.